Eli Lilly shares surge on a beat-and-raise, proving the stock’s swoon was a mistake

Obesity drug giant Eli Lilly on Thursday reported a monster first quarter, fortifying our conviction to stick with the stock after a period of sluggishness.

Tag: raise

Eli Lilly shares surge on a beat-and-raise, proving the stock’s swoon was a mistake

Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlook

More than 20,000 people are taking Eli Lilly’s weight loss pill Foundayo, CEO says

FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list in win for the companies

Eli Lilly shares surge on a beat-and-raise, proving the stock’s swoon was a mistake

Facebook Has a Health Scam Problem

Your Doctor’s Notes Might Be Written by an A.I. Algorithm. Here’s What to Know.

Cardio vs Strength Training: Do I Really Need to Do Both?